Guardant Health
GH
#2961
Rank
โ‚ฌ4.09 B
Marketcap
33,17ย โ‚ฌ
Share price
-2.19%
Change (1 day)
32.79%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚ฌ4.09 Billion

As of December 2024 Guardant Health has a market cap of โ‚ฌ4.09 Billion. This makes Guardant Health the world's 2961th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ4.09 B38.01%
2023โ‚ฌ2.97 B14.34%
2022โ‚ฌ2.59 B-71.07%
2021โ‚ฌ8.97 B-14.29%
2020โ‚ฌ10.47 B59.92%
2019โ‚ฌ6.55 B132.46%
2018โ‚ฌ2.81 B

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Guardant Health was reported to be:

โ‚ฌ4.09 Billion
by Nasdaq info icon info icon
โ‚ฌ4.09 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ21.14 B 415.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.50 B-38.94%๐Ÿ‡บ๐Ÿ‡ธ USA